Review of the first year in operation: Biotechs flock to EMEA’s SME office

Biotechs flock to EMEA’s SME officeEurope’s small biotechs have leapt to take advantage of the European Medicines Agency’s (EMEA) office for SMEs, according to a review of its first year in operation.

EMEAs SME office background:
http://www.emea.europa.eu/SME/SMEbackground.htm

Report from the SME Office on its first year of operation
http://www.emea.europa.eu/pdfs/SME/49858406en.pdf